Allergic rhinitis is a common medical problem in both the adult and the pediatric population. A main complication of this disease is a reduction in the patient's quality of life. Individuals with either seasonal or perennial allergic rhinitis often are impaired, adversely affecting work and/or school performance. This impairment can result from the disease itself and the treatment thereof. Oral antihistamines are the mainstay of treatment for allergic disease. First-generation antihistamines are considered sedating and frequently are impairing even when sedation is absent. Second-generation antihistamines show some class variability regarding impairment but as a group are clearly less impairing than their first-generation predecessors. Second-generation antihistamines are the preferred medication when antihistamines are necessary.
Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.